Acute L-Carnitine Supplementation Does Not Improve CrossFit® Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
Nutrients · 2025
DOI: 10.3390/nu17172784 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Asli Devrim-Lanpir und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Human Performance, Dublin City University, D09 V209 Dublin, Ireland. Hauptthemen laut MEDLINE: Carnitine, Dietary Supplements, Athletic Performance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
L-carnitine supplementation is thought to enhance exercise performance, particularly in moderate and high-intensity activities, but evidence supporting this is mixed. This study aimed to assess whether acute L-carnitine tartrate supplementation could improve CrossFit® performance, specifically during the “Cindy” workout, a high-intensity exercise protocol.
Methods
In a randomized, double-blind, placebo-controlled crossover design, 20 trained male recreational CrossFit® athletes completed the “Cindy” workout within a 20 min period after ingesting either 3 g of L-carnitine tartrate or a placebo 90 min before exercise. Performance was measured by total repetitions completed. Secondary outcomes included ratings of perceived exertion (RPE), gastrointestinal issues, and blood pressure (BP) measurements.
Results
The results showed that L-carnitine supplementation did not significantly affect the number of repetitions performed (202.4 ± 69.9 vs. 204.5 ± 78.8, p = 0.810) compared to the placebo. There were also no significant differences in RPE (6.3 ± 1.5 vs. 6.9 ± 1.4, p = 0.180) or BP changes between groups. However, 10% of participants reported difficulty sleeping after L-carnitine supplementation.
Conclusions
The findings suggest that 3 g of L-carnitine tartrate does not enhance CrossFit® performance in recreational athletes. Further research is needed to clarify its potential benefits, especially with larger samples and consideration of factors like sex and carbohydrate co-ingestion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health and Human Performance, Dublin City University, D09 V209 Dublin, Ireland.
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Medeniyet University, 34862 Istanbul, Turkey.
- Faculty of Higher Studies Zaragoza, National Autonomous University of Mexico, Mexico 09230, Mexico.
- Division of Sport and Exercise Science, School of Health and Life Sciences, University of the West of Scotland, Blantyre G72 0LH, UK.
- SRH Campus Hamburg, Berlin University of Applied Sciences, 20095 Hamburg, Germany.
- Medbase St. Gallen Am Vadianplatz, Vadianstrasse 26, 9001 St. Gallen, Switzerland.
ORCID-Profile: Asli Devrim-Lanpir, Azucena Ojeda Sanchez, Reza Zare, Beat Knechtle, Katja Weiss, Thomas Rosemann, Katie Heinrich
Zitieren
APA
Devrim-Lanpir, A., Velasco, L. S., Ramirez Lara, F. G., Ojeda Sanchez, A., Kimble, R., Zare, R., Gunes, F. E., Knechtle, B., Weiss, K., Rosemann, T., & Heinrich, K. (2025). Acute L-Carnitine Supplementation Does Not Improve CrossFit® Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. Nutrients. https://doi.org/10.3390/nu17172784
Vancouver
Devrim-Lanpir A, Velasco LS, Ramirez Lara FG, Ojeda Sanchez A, Kimble R, Zare R, et al. Acute L-Carnitine Supplementation Does Not Improve CrossFit® Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. Nutrients. 2025. doi:10.3390/nu17172784
BibTeX
@article{DevrimLanpir2025,
author = {Devrim-Lanpir, Asli and Velasco, Lucero Salazar and Ramirez Lara, Fanny Guadalupe and Ojeda Sanchez, Azucena and Kimble, Rachel and Zare, Reza and Gunes, Fatma Esra and Knechtle, Beat and Weiss, Katja and Rosemann, Thomas and Heinrich, Katie},
title = {Acute L-Carnitine Supplementation Does Not Improve CrossFit® Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Study},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17172784}
}
EUVIMED